Perfil
Lisa Amaya Price is currently Chief Human Resources Officer at Disc Medicine, Inc. since 2026.
Formerly, Ms. Price was Chief Human Resources Officer & Senior VP at Deciphera Pharmaceuticals, Inc. from 2022 to 2026 and Chief People Officer at LGC Group, Inc. Education includes graduate studies at Simmons University, undergraduate studies at Bard College, and an MBA from F.W.
Olin Graduate School of Business.
Cargos activos de Lisa Amaya Price
| Empresas | Cargo | Inicio |
|---|---|---|
| DISC MEDICINE, INC. | Oficial de Recursos Humanos | 12/01/2026 |
Antiguos cargos conocidos de Lisa Amaya Price.
| Empresas | Cargo | Fin |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 01/01/2026 |
LGC Group, Inc.
LGC Group, Inc. Medical SpecialtiesHealth Technology Develops life science tools, components and solutions | Oficial de Recursos Humanos | - |
Formación de Lisa Amaya Price.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Simmons University
Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bard College
Bard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F.W. Olin Graduate School of Business
F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
LGC Group, Inc.
LGC Group, Inc. Medical SpecialtiesHealth Technology Develops life science tools, components and solutions | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Lisa Amaya Price
















